|
|||||
|
|
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia |
|
| Authors: | Paolo Strati MD Hagop Kantarjian MD Deborah Thomas MD Susan O'Brien MD Sergej Konoplev MD PhD Jeffrey L. Jorgensen MD PhD Raja Luthra MD PhD Lynne Abruzzo MD PhD Elias Jabbour MD Alfonso Quintas‐Cardama MD Gautam Borthakur MD Stefan Faderl MD Farhad Ravandi MD Jorge Cortes MD |
| Affiliation: | 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | chronic myeloid leukemia blast phase lymphoid variant HCVAD tyrosine kinase inhibitors |